Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: VC Round Extensions Attractive While Stock Market Wobbles

2022 Ended With Just 22 Biopharma IPOs

06 Jan 2023

• By Mandy Jackson

Finance Watch Private Company — • Source: Shutterstock

Related Content

Reunited At Last At J.P. Morgan; Will The Sparks Still Fly?

04 Jan 2023

Finance Watch: IPOs At A Standstill As US Biotech Stock Valuations Plummet

28 Jan 2022

IPO Outlook: 2021 Saw Record Numbers But Poor Returns; 2022 Looks Muted

07 Jan 2022

Ensoma Launches With Takeda Partnership On Myeloablation-Free Gene Therapy

11 Feb 2021

New Company Twelve Bio Aims To Improve On CRISPR Gene-Editing Tech

09 Mar 2021

Finance Watch: Latest Slate Of VC Mega-Deals Led By China-Based Biopharmas

31 Mar 2021

Finance Watch: Insilico Raises $255m To Take AI-Discovered Drugs Into The Clinic

23 Jun 2021

Finance Watch: Two New VC Funds Raise $955m To Back Life Science Companies

23 Sep 2021

Apnimed Moves Closer To Phase III With Sleep Apnea Drug

13 Oct 2021

Deal Watch: Merck Looks To Technology Platform Partners For Cytokine Agonist Discovery, Drug Delivery

05 Nov 2021

Hepalink-Backed HighTide Bets On NASH For Global Markets

24 Apr 2019

Finance Watch: Notable Neuroscience VC Deals Include Nura Bio’s $73m Launch

04 Aug 2020

Finance Watch: One Small Pain Drug Maker And Three Biotech SPACs Launch IPOs

07 Sep 2020

Big Pharma’s $1Bn Antibiotic Development Fund Offers ‘Breathing Room’ For Reimbursement Fix

10 Jul 2020

Ionis Partners With Metagenomi To Expand Its Genetic Medicines Capabilities

14 Nov 2022

Finance Watch: Acrivon Adjusts Expectations To Launch $99.4m IPO

16 Nov 2022

Finance Watch: Prime Medicine Launches Second-Largest IPO In Second Half Of 2022

20 Oct 2022

Finance Watch: VC Mega-Rounds Are Alive And Well

11 May 2022

Finance Watch: Venture Floodgates Open With New Funds, Dozens Of Rounds

27 Jun 2022

Related Companies

Coya Therapeutics, Inc.

Prime Medicine, Inc.

Acrivon Therapeutics, Inc.

Apnimed

Metagenomi, Inc.

Synthekine Inc.

Merck & Co., Inc.

Amolyt Pharma

Belharra Therapeutics Inc.

Genentech, Inc.

HighTide Therapeutics Inc.

Ensoma

Takeda Pharmaceutical Co. Ltd.

Ophirex, Inc

Akamis Bio

Immune-Onc Therapeutics Inc.

BioVersys AG

Mantra Bio Inc.

Lumen Bioscience, Inc.

Additional Topics

StartUps and SMEs Financing Business Strategies Commercial Finance Watch BioPharmaceutical

More from Finance Watch

More from Financing

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.